ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial.
about
Image guided surgery for the resection of brain tumoursMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyIntraoperative Fluorescence Imaging for Personalized Brain Tumor Resection: Current State and Future Directions.Clinical utility of 5-aminolevulinic acid HCl to better visualize and more completely remove gliomas.Site-specific opening of the blood-brain barrier.Intraoperative assistive technologies and extent of resection in glioma surgery: a systematic review of prospective controlled studies.Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studiesDisruption of the blood-brain barrier following ALA-mediated photodynamic therapyThe effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroidsHexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, Fluorescence) and photodynamic therapyBiopsy versus resection for malignant glioma.Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapyMotexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.Review of Neurosurgical Fluorescence Imaging Methodologies.Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain.Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.Photochemical internalization-mediated nonviral gene transfection: polyamine core-shell nanoparticles as gene carrier.Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements.In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo.Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide genePhotodynamic therapy of cancer: an updatePhotodynamic therapy mediated by 5-aminolevulinic acid suppresses gliomas growth by decreasing the microvessels.Aminolevulinic acid-mediated photodynamic therapy of human meningioma: an in vitro study on primary cell lines.Optical Imaging, Photodynamic Therapy and Optically Triggered Combination Treatments.5-ALA Fluorescence Image Guided Resection of Glioblastoma Multiforme: A Meta-Analysis of the Literature.The role of photodynamic therapy in overcoming cancer drug resistance.Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium.Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.Selective accumulation of hematoporphyrin derivative in glioma through proton-coupled folate transporter SLC46A1.Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.Fluorescence Lifetime Spectroscopy and Imaging in Neurosurgery.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Nanotechnology applications for glioblastoma.Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders.Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro.Novel Surgical Approaches to High-Grade Gliomas.Imbalance of Ca2+ and K+ fluxes in C6 glioma cells after PDT measured with scanning ion-selective electrode technique.
P2860
Q24200959-68C9167D-BD1B-4E81-A8E7-0AB438AE2CD7Q27004205-35E001DF-E5FE-47C4-B94F-537A23C48416Q28073893-67779C58-9456-42FF-A77C-F4975CC85552Q28078505-5DA51490-2118-4021-8AD8-81706EDB59B1Q30434041-B21B9DD1-923E-4327-80F7-5065123AF3E9Q30873985-75DE0449-C447-4948-89D8-3AE32BDD1671Q31118506-84826B33-A3CE-4C59-A10A-7C413987BB1DQ33370158-B957E5E3-FAE9-4AFC-9400-1DFD91361676Q33500227-432939BE-3382-47B2-BB2C-168A319AD209Q33553797-0964F27B-5021-428F-8BB0-AF88810C62E9Q33910051-303B5BFC-34D7-4337-A5F3-CD08131A4D3BQ33955386-B851C1B0-D61F-41CD-B087-790AB6962BA5Q33975357-38E5E9CB-6AD7-4EC9-B7D2-522F591403B5Q34023717-56823D14-4F17-4A18-AFF8-46E306D9B562Q34050281-62E30F6A-DE38-4916-A5B5-1BBD978343D6Q34063357-CC15D599-EB32-4032-B1BE-0F2CC7ACF8A2Q34389909-7A1AAEB0-1BD0-48D1-BF2B-1E1A524B1113Q34513994-4F2132AC-C342-4997-8553-CF5DDCE9E95BQ34517469-88A4C4FE-974C-45EA-B03F-7CC5D4D290CAQ34586177-84A3E705-D243-484C-8815-DAB79A29ED0CQ35115061-AFEFBA03-F529-4460-9CB8-76A48AC6687EQ35532394-0B90E5DF-E8BF-4100-A2EC-6A11A34EC70BQ35602737-18A99D85-463F-41D2-80DD-B41F3A42901CQ35622314-182FBCA4-BC2B-4991-8B6E-F7C3C645773CQ35694223-93904B39-7917-4953-92F9-F0186D1C751EQ35723365-2238EFAD-3539-4654-A90C-68F292356829Q35904547-70DB658B-3D7A-4BB3-AF1E-B38A26277036Q36042421-94AF3F60-43C1-4C00-B5E1-89B94CC9EEB5Q36297034-8B644EA3-69FF-4D34-837A-CB2EA532902DQ36337106-14C93140-BDE5-4097-A280-6B702288922EQ37115994-DA25BBFA-8076-4CE2-B902-2E124B42D308Q37440350-19087FFC-F418-466D-8220-B4AE1068F0ECQ37525571-49627004-ADDF-4C3C-9404-3D612294CB70Q37548656-2680BB61-D6E1-47DC-A95D-37214107F9F3Q37676077-BD429853-DC83-4A1B-A247-8F9E0A1F8AC4Q38022853-FC2567D3-9E0E-40B6-9DD1-B4725A5570D7Q38147577-AB5DCE54-133C-424D-BF55-2E051609A363Q38617563-5B47DB44-AA2C-456A-A07E-C7A5DD7A9BD9Q38984380-6B12F87A-4B79-4E59-B5E2-2B577C538E44Q39031217-BB0E6FF0-B07E-47A3-8C1E-76DD673B3F28
P2860
ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@ast
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@en
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@nl
type
label
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@ast
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@en
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@nl
prefLabel
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@ast
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@en
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@nl
P2093
P1476
ALA and Photofrin fluorescence ...... I randomised controlled trial.
@en
P2093
Carol Goodman
Harry Moseley
M Sam Eljamel
P2860
P2888
P304
P356
10.1007/S10103-007-0494-2
P577
2007-10-10T00:00:00Z
P6179
1008065703